Role of Local Skin Incision Infiltration by Oxytocin On Wound Healing

Launched by EGYMEDICALPEDIA · Feb 23, 2023

Keywords

ClinConnect Summary

This clinical trial is investigating how a medication called oxytocin, when injected into the skin around the incision after a planned cesarean section, can help improve wound healing and reduce complications like infections and scars. In Egypt, the rate of cesarean sections is quite high, and issues with healing can lead to stress and a longer recovery for mothers. By studying the effects of oxytocin, researchers hope to find better ways to support women after surgery.

To participate in this study, women must be first-time mothers between 20 and 35 years old who are scheduled for a planned cesarean section. They should be at least 37 weeks pregnant but not more than 41 weeks. Participants will be closely monitored for their healing process after the surgery. It’s important to note that women with certain health conditions, or those who have had previous births, won't be eligible to join. This trial is currently recruiting participants, and mothers who take part could contribute to improving care for future patients.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Primigravidae women,
• • Age group from 20- 35 years old.
• • Gestational age 37-41 weeks, and
• • Elective caesarean section due to obstetrics indication.
• • The patient signed an Informed Consent Form authorizing their inclusion
• Exclusion Criteria:
• • Multiparous women,
• • Assisted vaginal delivery,
• • Normal vaginal delivery,
• • Emergency caesarean section,
• • Preterm pre labour rupture of membrane,
• • Primiparous women with age above 35 years old,
• • Primiparous women with known connective tissue disease and
• • Women suffering from chronic diseases such as diabetes, hypertension, cardiovascular diseases, psychiatric diseases, cancer
• • Smoking Women